UK Primary Care Poc Diagnostics Market Size & Outlook
UK primary care poc diagnostics market, 2018-2030 (US$M)
Related Markets
UK primary care poc diagnostics market highlights
- The UK primary care poc diagnostics market generated a revenue of USD 75.6 million in 2024 and is expected to reach USD 107.4 million by 2030.
- The UK market is expected to grow at a CAGR of 5.6% from 2025 to 2030.
- In terms of segment, infectious diseases was the largest revenue generating product in 2024.
- Cancer Marker is the most lucrative product segment registering the fastest growth during the forecast period.
Primary care poc diagnostics market data book summary
| Market revenue in 2024 | USD 75.6 million |
| Market revenue in 2030 | USD 107.4 million |
| Growth rate | 5.6% (CAGR from 2025 to 2030) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Cancer Marker |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Glucose Testing, Hb1Ac Testing, Coagulation, Fertility/Pregnancy, Infectious Diseases, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug Abuse Testing, Autoimmune Disease, Urinalysis/Nephrology |
| Key market players worldwide | Roche Holding AG ADR, BD, Danaher Corp, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Johnson & Johnson Services, Inc., Becton Dickinson & Co, OraSure Technologies Inc |
Other key industry trends
- In terms of revenue, UK accounted for 5.8% of the global primary care poc diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany primary care poc diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 107.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Primary Care POC Diagnostics Market Scope
Primary Care POC Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK primary care poc diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to primary care poc diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 30.95% in 2024. Horizon Databook has segmented the UK primary care poc diagnostics market based on glucose testing, hb1ac testing, coagulation, fertility/pregnancy, infectious diseases, cardiac markers, thyroid stimulating hormone, hematology, primary care systems, decentralized clinical chemistry, feces, lipid testing, cancer marker, blood gas/electrolytes, ambulatory chemistry, drug abuse testing, autoimmune disease, urinalysis/nephrology covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to UK primary care poc diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK primary care poc diagnostics market databook
-
Our clientele includes a mix of primary care poc diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK primary care poc diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UK primary care poc diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK primary care poc diagnostics market size, by end use, 2018-2030 (US$M)
UK Primary Care POC Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
